Search Results 1511-1520 of 18396 for Immunode
- Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months prior to ...
- Known human immunodeficiency virus (HIV) infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months prior to
Elvitegravir, cobicistat, emtricitabine, and tenofovir combination is used to treat human immunodeficiency virus (HIV) infection. HIV is the virus that ...
- Immunocompromised patients and patients known to be human immunodeficiency virus (HIV) positive and currently receiving antiretroviral therapy - NOTE ...
Subjects with poorly controlled human immunodeficiency virus, hepatitis B virus, and/or hepatitis C virus infections. 23. Known allergies to nab-paclitaxel ...
... immunodeficiency virus, or who have recurrent or chronic systemic bacterial, fungal, viral or protozoal infections;; Major episode of infection requiring ...
Known history of human immunodeficiency virus (HIV) infection. Testing for HIV status is not necessary unless clinically indicated. Active hepatitis B virus ...
Seroreactivity for human immunodeficiency virus (HIV), human T-lymphotropic virus type I (HTLV I) or II, hepatitis B virus (HBV), hepatitis C virus (HCV) ...
... immunodeficiency virus (HIV) antibody at the Screening Visit or documented in the medical chart within the last 1 year;; Subjects must be willing and able to ...
- Human immunodeficiency virus (HIV) infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.